Why did Renasant repurchase shares in Q2 2026?

The company repurchased shares as part of its capital management strategy to return value to shareholders while maintaining strong capital ratios. The bank generated solid earnings (net income of $87.1 million in Q2) and management expressed confidence in operating performance, supporting the deployment of excess capital.

How much of the $250M authorization has been used?

As of June 30, 2026, approximately $148.2 million has been deployed ($250M authorized minus $101.8M remaining). This represents about 59% utilization with roughly four months remaining before the October 2026 expiration.

What happens if the authorization is not fully used by October 2026?

The filing states the program will terminate at the earlier of October 2026 or full execution of the $250 million authorization. Any unused balance will expire and the board would need to authorize a new repurchase program to continue buybacks.

How many shares did the Q2 repurchase remove from circulation?

At the weighted average price of $39.54, the $60 million Q2 repurchase reduced shares outstanding by approximately 1.5 million shares, bringing the count from 92.9 million at quarter-end March to 91.4 million at quarter-end June.

Is this buyback unusual for Renasant given the merger activity mentioned?

The company completed a significant merger in 2025 (referenced in the text) and is in the post-integration phase. The Q2 buyback reflects management's view that integration is progressing well and that the company has sufficient capital above regulatory and operational needs to return to shareholders via repurchases.

RNST 8-K Filed 2026-07-28 Execution disclosure

Renasant repurchased $60M shares at $39.54 avg in Q2 2026

Bank continues $250M buyback plan with $101.8M remaining; shares repurchased reduced count by ~1.5M

Avg price paid$39.54

Remaining$102M

MechanismOpen-market purchases or priva

What the filing says

Renasant Corporation repurchased $60.0 million of common stock during the second quarter of 2026 at a weighted average price of $39.54 per share. As of June 30, 2026, $101.8 million in repurchase authorization remained available under the company's $250.0 million stock repurchase program, which is set to expire in October 2026 or upon full execution of the authorized amount, whichever comes first.

The repurchase activity reduced shares outstanding from approximately 92.9 million at March 31, 2026 to 91.4 million at June 30, 2026. The execution mechanism was open-market purchases or privately negotiated transactions under the existing authorization. This activity occurred alongside the company's announcement of a quarterly dividend increase to $0.24 per share effective April 28, 2026.

The buyback supports the company's capital management strategy in a period of strong earnings performance. Net income for the second quarter was $87.1 million, with diluted EPS of $0.94. Book value per share increased 1.7% and tangible book value per share increased 1.4% linked quarter, reflecting the balance between earnings accretion and share count reduction.

1517841

The Company has a $250.0 million stock repurchase program under which the Company is authorized to repurchase outstanding shares of its common stock either in open market purchases or privately negotiated transactions. The program will remain in effect until the earlier of October 2026 or the repurchase of the entire amount authorized under the plan. During the second quarter of 2026, the Company repurchased $60.0 million of common stock at a weighted average price of $39.54. — RENASANT CORP 8-K filing · View on SEC EDGAR →

What this means

Renasant deployed $60 million of its $250 million authorization in Q2, representing roughly 24% utilization to date with roughly six months remaining before program expiration. At the executed price of $39.54, the company reduced share count by approximately 1.5 million shares, benefiting per-share metrics. With $101.8 million remaining and an October 2026 deadline, the company has capacity to repurchase roughly 2.6 million additional shares at current price levels. The buyback is integrated into a broader capital-return framework that includes a dividend increase, reflecting management confidence in earnings and capital generation amid a post-merger integration period.

Frequently asked questions

Why did Renasant repurchase shares in Q2 2026?: The company repurchased shares as part of its capital management strategy to return value to shareholders while maintaining strong capital ratios. The bank generated solid earnings (net income of $87.1 million in Q2) and management expressed confidence in operating performance, supporting the deployment of excess capital.
How much of the $250M authorization has been used?: As of June 30, 2026, approximately $148.2 million has been deployed ($250M authorized minus $101.8M remaining). This represents about 59% utilization with roughly four months remaining before the October 2026 expiration.
What happens if the authorization is not fully used by October 2026?: The filing states the program will terminate at the earlier of October 2026 or full execution of the $250 million authorization. Any unused balance will expire and the board would need to authorize a new repurchase program to continue buybacks.
How many shares did the Q2 repurchase remove from circulation?: At the weighted average price of $39.54, the $60 million Q2 repurchase reduced shares outstanding by approximately 1.5 million shares, bringing the count from 92.9 million at quarter-end March to 91.4 million at quarter-end June.
Is this buyback unusual for Renasant given the merger activity mentioned?: The company completed a significant merger in 2025 (referenced in the text) and is in the post-integration phase. The Q2 buyback reflects management's view that integration is progressing well and that the company has sufficient capital above regulatory and operational needs to return to shareholders via repurchases.

execution banking-sector rule-10b-18 capital-management regional-bank

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.